ATNM
#4502
Actinium Pharmaceuticals, Inc. Common Stock
0.8 9 USD
-0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.26%
Variación mensual
-16.04%
Variación en los últimos 6 meses
-14.42%
Cambio anual
-14.42%
Cierres anteriores
0.9 2
Open
0.8 9
Mínimo
0.8 9
High
0.8 9
Volumen
7
Financials
- Market Capitalization 27.92 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.31
Relación precio/flujo de caja
344.99
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4487 |  DARE Dare Bioscience, Inc. - Common Stock | 1.94 USD | -6.28% | -5.83% | -6.73% | +17.58% | 29.06 M USD | ||
| 4490 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 3.08 USD | +5.12% | -19.79% | +18.46% | -14.44% | 28.89 M USD | ||
| 4503 |  BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.67 USD | +3.08% | +9.84% | -1.47% | -58.13% | 27.37 M USD | ||
| 4507 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.87 USD | -5.43% | +4.82% | -27.50% | -44.94% | 26.86 M USD |